Using T cells to kill cancer cells with TRAIL
Author Information
Author(s): Ucur E, Mattern J, Wenger T, Okouoyo S, Schroth A, Debatin K-M, Herr I
Primary Institution: German Cancer Research Center, Heidelberg, Germany
Hypothesis
Can TRAIL-expressing T cells induce apoptosis in human B cell lymphomas?
Conclusion
TRAIL-expressing T cells can effectively induce apoptosis in human Burkitt lymphoma cells and enhance the effects of chemotherapy.
Supporting Evidence
- TRAIL-expressing T cells induced strong apoptosis in Burkitt lymphoma cells.
- Jurkat-TRAIL cells were resistant to TRAIL-induced apoptosis themselves.
- Combination of TRAIL with chemotherapy significantly increased cell death in target cells.
- Jurkat-TRAIL cells inhibited tumor growth in xenograft models.
Takeaway
Scientists created special T cells that can help kill cancer cells by using a protein called TRAIL, which makes the cancer cells die.
Methodology
The study used a T-cell line engineered to express TRAIL under a controlled system, which was tested in vitro and in vivo against Burkitt lymphoma cells.
Potential Biases
Potential bias in the selection of cell lines and the experimental conditions used.
Limitations
The study primarily focused on a specific type of lymphoma and may not be generalizable to all cancer types.
Participant Demographics
The study involved human Burkitt lymphoma cells and T-cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website